ERBB2 and breast neoplasm: We recently reported that in HR+/HER2- breast tumors analyzed before and after NAC, sTIL and CD8+ cells were significantly decreased after treatment, whereas expression analyses revealed that there was increased expression of immunosuppressive (M2-like) macrophage-specific genes after chemotherapy.